title: Reply to Lauhio et al.
authors.affiliation: Department of Clinical Medicine, University of Helsinki Inflammation Center, Clinic of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Finland Unit of Infectious Diseases, Karolinska Institutet, Solna, Stockholm, Sweden.
authors.forename: Anu
authors.initials: A
authors.lastname: Kantele
authors.affiliation: Department of Clinical Medicine, University of Helsinki Inflammation Center, Clinic of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Finland.
authors.forename: Tinja
authors.initials: T
authors.lastname: Lääveri
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004755:Enterobacteriaceae / Q000254:growth & development* / Q000302:isolation & purification*; D004756:Enterobacteriaceae Infections / Q000453:epidemiology*; D005243:Feces / Q000382:microbiology*; D005260:Female; D006801:Humans; D008297:Male; D014195:Travel; D001618:beta-Lactamases / Q000096:biosynthesis*
chemical_list: D000900:Anti-Bacterial Agents; D001618:beta-Lactamases